Corpus GrippeAllemagneV3

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.

Identifieur interne : 000289 ( Main/Exploration ); précédent : 000288; suivant : 000290

Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.

Auteurs : Bijan Raziorrouh [Allemagne] ; Axel Ulsenheimer ; Winfried Schraut ; Malte Heeg ; Peter Kurktschiev ; Reinhart Zachoval ; Maria-Christina Jung ; Robert Thimme ; Christoph Neumann-Haefelin ; Sophia Horster ; Martin W Chtler ; Michael Spannagl ; Jürgen Haas ; Helmut M. Diepolder ; Norbert H. Grüner

Source :

RBID : pubmed:21763239

Descripteurs français

English descriptors

Abstract

BACKGROUND & AIMS

Inhibitory receptors such as programmed death 1 (PD-1) and cytotoxic T lymphocyte-associated antigen (CTLA)-4 mediate CD8+ T-cell exhaustion during chronic viral infection, but little is known about roles in dysfunction of CD4+ T cells.

METHODS

We investigated the functions of inhibitory molecules on hepatitis C virus (HCV)-, influenza-, and Epstein-Barr virus (EBV)-specific CD4+ T cells in patients with chronic infections compared with patients with resolved HCV infection and healthy donors. Expression of PD-1, CTLA-4, CD305, and CD200R were analyzed on HCV-specific CD4+ T cells, isolated from peripheral blood using major histocompatibility complex class II tetramers. We investigated the effects of in vitro inhibition of various inhibitory pathways on proliferation and cytokine production by CD4+ T cells, and we compared these effects with those from inhibition of interleukin (IL)-10 and transforming growth factor (TGF)-β1.

RESULTS

PD-1 and CTLA-4 were up-regulated on virus-specific CD4+ T cells from patients with chronic HCV infections. PD-1 expression was lower on influenza- than on HCV-specific CD4+ T cells from subjects with chronic HCV infection, whereas CTLA-4 was expressed at similar levels, independent of their specificity. CD305 and CD200R were up-regulated in HCV resolvers. Blockade of PD-L1/2, IL-10, and TGF-β1 increased expansion of CD4+ T cells in patients with chronic HCV, whereas inhibition of IL-10 and TGF-β1 was most effective in restoring HCV-specific production of interferon gamma, IL-2, and tumor necrosis factor α.

CONCLUSIONS

We characterized expression of inhibitory molecules on HCV-, influenza-, and EBV-specific CD4+ T cells and the effects of in vitro blockade on CD4+ T-cell expansion and cytokine production. Inhibition of PD-1, IL-10, and TGF-β1 is most efficient in restoration of HCV-specific CD4+ T cells.


DOI: 10.1053/j.gastro.2011.07.004
PubMed: 21763239


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.</title>
<author>
<name sortKey="Raziorrouh, Bijan" sort="Raziorrouh, Bijan" uniqKey="Raziorrouh B" first="Bijan" last="Raziorrouh">Bijan Raziorrouh</name>
<affiliation wicri:level="3">
<nlm:affiliation>Medical Department II, University Hospital of Ludwig-Maximillians-University, and Institute for Immunology, Ludwig-Maximilians-University, Munich, Germany. bijan.raziorrouh@med.uni-muenchen.de</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Medical Department II, University Hospital of Ludwig-Maximillians-University, and Institute for Immunology, Ludwig-Maximilians-University, Munich</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ulsenheimer, Axel" sort="Ulsenheimer, Axel" uniqKey="Ulsenheimer A" first="Axel" last="Ulsenheimer">Axel Ulsenheimer</name>
</author>
<author>
<name sortKey="Schraut, Winfried" sort="Schraut, Winfried" uniqKey="Schraut W" first="Winfried" last="Schraut">Winfried Schraut</name>
</author>
<author>
<name sortKey="Heeg, Malte" sort="Heeg, Malte" uniqKey="Heeg M" first="Malte" last="Heeg">Malte Heeg</name>
</author>
<author>
<name sortKey="Kurktschiev, Peter" sort="Kurktschiev, Peter" uniqKey="Kurktschiev P" first="Peter" last="Kurktschiev">Peter Kurktschiev</name>
</author>
<author>
<name sortKey="Zachoval, Reinhart" sort="Zachoval, Reinhart" uniqKey="Zachoval R" first="Reinhart" last="Zachoval">Reinhart Zachoval</name>
</author>
<author>
<name sortKey="Jung, Maria Christina" sort="Jung, Maria Christina" uniqKey="Jung M" first="Maria-Christina" last="Jung">Maria-Christina Jung</name>
</author>
<author>
<name sortKey="Thimme, Robert" sort="Thimme, Robert" uniqKey="Thimme R" first="Robert" last="Thimme">Robert Thimme</name>
</author>
<author>
<name sortKey="Neumann Haefelin, Christoph" sort="Neumann Haefelin, Christoph" uniqKey="Neumann Haefelin C" first="Christoph" last="Neumann-Haefelin">Christoph Neumann-Haefelin</name>
</author>
<author>
<name sortKey="Horster, Sophia" sort="Horster, Sophia" uniqKey="Horster S" first="Sophia" last="Horster">Sophia Horster</name>
</author>
<author>
<name sortKey="W Chtler, Martin" sort="W Chtler, Martin" uniqKey="W Chtler M" first="Martin" last="W Chtler">Martin W Chtler</name>
</author>
<author>
<name sortKey="Spannagl, Michael" sort="Spannagl, Michael" uniqKey="Spannagl M" first="Michael" last="Spannagl">Michael Spannagl</name>
</author>
<author>
<name sortKey="Haas, Jurgen" sort="Haas, Jurgen" uniqKey="Haas J" first="Jürgen" last="Haas">Jürgen Haas</name>
</author>
<author>
<name sortKey="Diepolder, Helmut M" sort="Diepolder, Helmut M" uniqKey="Diepolder H" first="Helmut M" last="Diepolder">Helmut M. Diepolder</name>
</author>
<author>
<name sortKey="Gruner, Norbert H" sort="Gruner, Norbert H" uniqKey="Gruner N" first="Norbert H" last="Grüner">Norbert H. Grüner</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:21763239</idno>
<idno type="pmid">21763239</idno>
<idno type="doi">10.1053/j.gastro.2011.07.004</idno>
<idno type="wicri:Area/Main/Corpus">000272</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000272</idno>
<idno type="wicri:Area/Main/Curation">000272</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000272</idno>
<idno type="wicri:Area/Main/Exploration">000272</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.</title>
<author>
<name sortKey="Raziorrouh, Bijan" sort="Raziorrouh, Bijan" uniqKey="Raziorrouh B" first="Bijan" last="Raziorrouh">Bijan Raziorrouh</name>
<affiliation wicri:level="3">
<nlm:affiliation>Medical Department II, University Hospital of Ludwig-Maximillians-University, and Institute for Immunology, Ludwig-Maximilians-University, Munich, Germany. bijan.raziorrouh@med.uni-muenchen.de</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Medical Department II, University Hospital of Ludwig-Maximillians-University, and Institute for Immunology, Ludwig-Maximilians-University, Munich</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ulsenheimer, Axel" sort="Ulsenheimer, Axel" uniqKey="Ulsenheimer A" first="Axel" last="Ulsenheimer">Axel Ulsenheimer</name>
</author>
<author>
<name sortKey="Schraut, Winfried" sort="Schraut, Winfried" uniqKey="Schraut W" first="Winfried" last="Schraut">Winfried Schraut</name>
</author>
<author>
<name sortKey="Heeg, Malte" sort="Heeg, Malte" uniqKey="Heeg M" first="Malte" last="Heeg">Malte Heeg</name>
</author>
<author>
<name sortKey="Kurktschiev, Peter" sort="Kurktschiev, Peter" uniqKey="Kurktschiev P" first="Peter" last="Kurktschiev">Peter Kurktschiev</name>
</author>
<author>
<name sortKey="Zachoval, Reinhart" sort="Zachoval, Reinhart" uniqKey="Zachoval R" first="Reinhart" last="Zachoval">Reinhart Zachoval</name>
</author>
<author>
<name sortKey="Jung, Maria Christina" sort="Jung, Maria Christina" uniqKey="Jung M" first="Maria-Christina" last="Jung">Maria-Christina Jung</name>
</author>
<author>
<name sortKey="Thimme, Robert" sort="Thimme, Robert" uniqKey="Thimme R" first="Robert" last="Thimme">Robert Thimme</name>
</author>
<author>
<name sortKey="Neumann Haefelin, Christoph" sort="Neumann Haefelin, Christoph" uniqKey="Neumann Haefelin C" first="Christoph" last="Neumann-Haefelin">Christoph Neumann-Haefelin</name>
</author>
<author>
<name sortKey="Horster, Sophia" sort="Horster, Sophia" uniqKey="Horster S" first="Sophia" last="Horster">Sophia Horster</name>
</author>
<author>
<name sortKey="W Chtler, Martin" sort="W Chtler, Martin" uniqKey="W Chtler M" first="Martin" last="W Chtler">Martin W Chtler</name>
</author>
<author>
<name sortKey="Spannagl, Michael" sort="Spannagl, Michael" uniqKey="Spannagl M" first="Michael" last="Spannagl">Michael Spannagl</name>
</author>
<author>
<name sortKey="Haas, Jurgen" sort="Haas, Jurgen" uniqKey="Haas J" first="Jürgen" last="Haas">Jürgen Haas</name>
</author>
<author>
<name sortKey="Diepolder, Helmut M" sort="Diepolder, Helmut M" uniqKey="Diepolder H" first="Helmut M" last="Diepolder">Helmut M. Diepolder</name>
</author>
<author>
<name sortKey="Gruner, Norbert H" sort="Gruner, Norbert H" uniqKey="Gruner N" first="Norbert H" last="Grüner">Norbert H. Grüner</name>
</author>
</analytic>
<series>
<title level="j">Gastroenterology</title>
<idno type="eISSN">1528-0012</idno>
<imprint>
<date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antibodies, Neutralizing</term>
<term>Antigens, CD (immunology)</term>
<term>Antigens, CD (metabolism)</term>
<term>Antigens, Surface (metabolism)</term>
<term>CD4-Positive T-Lymphocytes (immunology)</term>
<term>CD4-Positive T-Lymphocytes (virology)</term>
<term>CTLA-4 Antigen (metabolism)</term>
<term>Case-Control Studies</term>
<term>Cell Proliferation</term>
<term>Cells, Cultured</term>
<term>Female</term>
<term>Germany</term>
<term>Hepacivirus (genetics)</term>
<term>Hepacivirus (immunology)</term>
<term>Hepatitis C, Chronic (diagnosis)</term>
<term>Hepatitis C, Chronic (immunology)</term>
<term>Herpesvirus 4, Human (immunology)</term>
<term>Humans</term>
<term>Interferon-gamma (metabolism)</term>
<term>Interleukin-10 (immunology)</term>
<term>Interleukin-10 (metabolism)</term>
<term>Interleukin-2 (metabolism)</term>
<term>Lymphocyte Activation</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Orthomyxoviridae (immunology)</term>
<term>Programmed Cell Death 1 Receptor (metabolism)</term>
<term>RNA, Viral (blood)</term>
<term>Receptors, Cell Surface (metabolism)</term>
<term>Transforming Growth Factor beta1 (immunology)</term>
<term>Transforming Growth Factor beta1 (metabolism)</term>
<term>Tumor Necrosis Factor-alpha (metabolism)</term>
<term>Viral Load</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>ARN viral (sang)</term>
<term>Activation des lymphocytes</term>
<term>Adulte d'âge moyen</term>
<term>Allemagne</term>
<term>Anticorps neutralisants</term>
<term>Antigène CTLA-4 (métabolisme)</term>
<term>Antigènes CD (immunologie)</term>
<term>Antigènes CD (métabolisme)</term>
<term>Antigènes de surface (métabolisme)</term>
<term>Cellules cultivées</term>
<term>Charge virale</term>
<term>Facteur de croissance transformant bêta-1 (immunologie)</term>
<term>Facteur de croissance transformant bêta-1 (métabolisme)</term>
<term>Facteur de nécrose tumorale alpha (métabolisme)</term>
<term>Femelle</term>
<term>Hepacivirus (génétique)</term>
<term>Hepacivirus (immunologie)</term>
<term>Herpèsvirus humain de type 4 (immunologie)</term>
<term>Humains</term>
<term>Hépatite C chronique (diagnostic)</term>
<term>Hépatite C chronique (immunologie)</term>
<term>Interféron gamma (métabolisme)</term>
<term>Interleukine-10 (immunologie)</term>
<term>Interleukine-10 (métabolisme)</term>
<term>Interleukine-2 (métabolisme)</term>
<term>Lymphocytes T CD4+ (immunologie)</term>
<term>Lymphocytes T CD4+ (virologie)</term>
<term>Mâle</term>
<term>Orthomyxoviridae (immunologie)</term>
<term>Prolifération cellulaire</term>
<term>Récepteur-1 de mort cellulaire programmée (métabolisme)</term>
<term>Récepteurs de surface cellulaire (métabolisme)</term>
<term>Études cas-témoins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en">
<term>RNA, Viral</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en">
<term>Antigens, CD</term>
<term>Interleukin-10</term>
<term>Transforming Growth Factor beta1</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Antigens, CD</term>
<term>Antigens, Surface</term>
<term>CTLA-4 Antigen</term>
<term>Interferon-gamma</term>
<term>Interleukin-10</term>
<term>Interleukin-2</term>
<term>Programmed Cell Death 1 Receptor</term>
<term>Receptors, Cell Surface</term>
<term>Transforming Growth Factor beta1</term>
<term>Tumor Necrosis Factor-alpha</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>Antibodies, Neutralizing</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en">
<term>Germany</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Hepatitis C, Chronic</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Hépatite C chronique</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Hepacivirus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Hepacivirus</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Antigènes CD</term>
<term>Facteur de croissance transformant bêta-1</term>
<term>Hepacivirus</term>
<term>Herpèsvirus humain de type 4</term>
<term>Hépatite C chronique</term>
<term>Interleukine-10</term>
<term>Lymphocytes T CD4+</term>
<term>Orthomyxoviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>CD4-Positive T-Lymphocytes</term>
<term>Hepacivirus</term>
<term>Hepatitis C, Chronic</term>
<term>Herpesvirus 4, Human</term>
<term>Orthomyxoviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Antigène CTLA-4</term>
<term>Antigènes CD</term>
<term>Antigènes de surface</term>
<term>Facteur de croissance transformant bêta-1</term>
<term>Facteur de nécrose tumorale alpha</term>
<term>Interféron gamma</term>
<term>Interleukine-10</term>
<term>Interleukine-2</term>
<term>Récepteur-1 de mort cellulaire programmée</term>
<term>Récepteurs de surface cellulaire</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr">
<term>ARN viral</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Lymphocytes T CD4+</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>CD4-Positive T-Lymphocytes</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Case-Control Studies</term>
<term>Cell Proliferation</term>
<term>Cells, Cultured</term>
<term>Female</term>
<term>Humans</term>
<term>Lymphocyte Activation</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Viral Load</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Activation des lymphocytes</term>
<term>Adulte d'âge moyen</term>
<term>Allemagne</term>
<term>Anticorps neutralisants</term>
<term>Cellules cultivées</term>
<term>Charge virale</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Prolifération cellulaire</term>
<term>Études cas-témoins</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Allemagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>BACKGROUND & AIMS</b>
</p>
<p>Inhibitory receptors such as programmed death 1 (PD-1) and cytotoxic T lymphocyte-associated antigen (CTLA)-4 mediate CD8+ T-cell exhaustion during chronic viral infection, but little is known about roles in dysfunction of CD4+ T cells.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>METHODS</b>
</p>
<p>We investigated the functions of inhibitory molecules on hepatitis C virus (HCV)-, influenza-, and Epstein-Barr virus (EBV)-specific CD4+ T cells in patients with chronic infections compared with patients with resolved HCV infection and healthy donors. Expression of PD-1, CTLA-4, CD305, and CD200R were analyzed on HCV-specific CD4+ T cells, isolated from peripheral blood using major histocompatibility complex class II tetramers. We investigated the effects of in vitro inhibition of various inhibitory pathways on proliferation and cytokine production by CD4+ T cells, and we compared these effects with those from inhibition of interleukin (IL)-10 and transforming growth factor (TGF)-β1.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>RESULTS</b>
</p>
<p>PD-1 and CTLA-4 were up-regulated on virus-specific CD4+ T cells from patients with chronic HCV infections. PD-1 expression was lower on influenza- than on HCV-specific CD4+ T cells from subjects with chronic HCV infection, whereas CTLA-4 was expressed at similar levels, independent of their specificity. CD305 and CD200R were up-regulated in HCV resolvers. Blockade of PD-L1/2, IL-10, and TGF-β1 increased expansion of CD4+ T cells in patients with chronic HCV, whereas inhibition of IL-10 and TGF-β1 was most effective in restoring HCV-specific production of interferon gamma, IL-2, and tumor necrosis factor α.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>CONCLUSIONS</b>
</p>
<p>We characterized expression of inhibitory molecules on HCV-, influenza-, and EBV-specific CD4+ T cells and the effects of in vitro blockade on CD4+ T-cell expansion and cytokine production. Inhibition of PD-1, IL-10, and TGF-β1 is most efficient in restoration of HCV-specific CD4+ T cells.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">21763239</PMID>
<DateCompleted>
<Year>2011</Year>
<Month>11</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised>
<Year>2011</Year>
<Month>10</Month>
<Day>04</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1528-0012</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>141</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2011</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Gastroenterology</Title>
<ISOAbbreviation>Gastroenterology</ISOAbbreviation>
</Journal>
<ArticleTitle>Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.</ArticleTitle>
<Pagination>
<MedlinePgn>1422-31, 1431.e1-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1053/j.gastro.2011.07.004</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND & AIMS" NlmCategory="OBJECTIVE">Inhibitory receptors such as programmed death 1 (PD-1) and cytotoxic T lymphocyte-associated antigen (CTLA)-4 mediate CD8+ T-cell exhaustion during chronic viral infection, but little is known about roles in dysfunction of CD4+ T cells.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We investigated the functions of inhibitory molecules on hepatitis C virus (HCV)-, influenza-, and Epstein-Barr virus (EBV)-specific CD4+ T cells in patients with chronic infections compared with patients with resolved HCV infection and healthy donors. Expression of PD-1, CTLA-4, CD305, and CD200R were analyzed on HCV-specific CD4+ T cells, isolated from peripheral blood using major histocompatibility complex class II tetramers. We investigated the effects of in vitro inhibition of various inhibitory pathways on proliferation and cytokine production by CD4+ T cells, and we compared these effects with those from inhibition of interleukin (IL)-10 and transforming growth factor (TGF)-β1.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">PD-1 and CTLA-4 were up-regulated on virus-specific CD4+ T cells from patients with chronic HCV infections. PD-1 expression was lower on influenza- than on HCV-specific CD4+ T cells from subjects with chronic HCV infection, whereas CTLA-4 was expressed at similar levels, independent of their specificity. CD305 and CD200R were up-regulated in HCV resolvers. Blockade of PD-L1/2, IL-10, and TGF-β1 increased expansion of CD4+ T cells in patients with chronic HCV, whereas inhibition of IL-10 and TGF-β1 was most effective in restoring HCV-specific production of interferon gamma, IL-2, and tumor necrosis factor α.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We characterized expression of inhibitory molecules on HCV-, influenza-, and EBV-specific CD4+ T cells and the effects of in vitro blockade on CD4+ T-cell expansion and cytokine production. Inhibition of PD-1, IL-10, and TGF-β1 is most efficient in restoration of HCV-specific CD4+ T cells.</AbstractText>
<CopyrightInformation>Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Raziorrouh</LastName>
<ForeName>Bijan</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Medical Department II, University Hospital of Ludwig-Maximillians-University, and Institute for Immunology, Ludwig-Maximilians-University, Munich, Germany. bijan.raziorrouh@med.uni-muenchen.de</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ulsenheimer</LastName>
<ForeName>Axel</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Schraut</LastName>
<ForeName>Winfried</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Heeg</LastName>
<ForeName>Malte</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kurktschiev</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Zachoval</LastName>
<ForeName>Reinhart</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Jung</LastName>
<ForeName>Maria-Christina</ForeName>
<Initials>MC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Thimme</LastName>
<ForeName>Robert</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Neumann-Haefelin</LastName>
<ForeName>Christoph</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Horster</LastName>
<ForeName>Sophia</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wächtler</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Spannagl</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Haas</LastName>
<ForeName>Jürgen</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Diepolder</LastName>
<ForeName>Helmut M</ForeName>
<Initials>HM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Grüner</LastName>
<ForeName>Norbert H</ForeName>
<Initials>NH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2011</Year>
<Month>07</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Gastroenterology</MedlineTA>
<NlmUniqueID>0374630</NlmUniqueID>
<ISSNLinking>0016-5085</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015703">Antigens, CD</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000954">Antigens, Surface</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C477337">CD200R1 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D060908">CTLA-4 Antigen</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C508609">IL10 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C508594">IL2 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007376">Interleukin-2</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C105992">PDCD1 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D061026">Programmed Cell Death 1 Receptor</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011956">Receptors, Cell Surface</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C508960">TGFB1 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D053773">Transforming Growth Factor beta1</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>130068-27-8</RegistryNumber>
<NameOfSubstance UI="D016753">Interleukin-10</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>82115-62-6</RegistryNumber>
<NameOfSubstance UI="D007371">Interferon-gamma</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015703" MajorTopicYN="N">Antigens, CD</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000954" MajorTopicYN="N">Antigens, Surface</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D060908" MajorTopicYN="N">CTLA-4 Antigen</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D049109" MajorTopicYN="Y">Cell Proliferation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016174" MajorTopicYN="N">Hepacivirus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019698" MajorTopicYN="N">Hepatitis C, Chronic</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004854" MajorTopicYN="N">Herpesvirus 4, Human</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007371" MajorTopicYN="N">Interferon-gamma</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016753" MajorTopicYN="N">Interleukin-10</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007376" MajorTopicYN="N">Interleukin-2</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008213" MajorTopicYN="Y">Lymphocyte Activation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009975" MajorTopicYN="N">Orthomyxoviridae</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D061026" MajorTopicYN="N">Programmed Cell Death 1 Receptor</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011956" MajorTopicYN="N">Receptors, Cell Surface</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053773" MajorTopicYN="N">Transforming Growth Factor beta1</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2010</Year>
<Month>09</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2011</Year>
<Month>06</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2011</Year>
<Month>07</Month>
<Day>05</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2011</Year>
<Month>7</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2011</Year>
<Month>7</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2011</Year>
<Month>12</Month>
<Day>13</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">21763239</ArticleId>
<ArticleId IdType="pii">S0016-5085(11)00942-5</ArticleId>
<ArticleId IdType="doi">10.1053/j.gastro.2011.07.004</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Allemagne</li>
</country>
<region>
<li>Bavière</li>
<li>District de Haute-Bavière</li>
</region>
<settlement>
<li>Munich</li>
</settlement>
</list>
<tree>
<noCountry>
<name sortKey="Diepolder, Helmut M" sort="Diepolder, Helmut M" uniqKey="Diepolder H" first="Helmut M" last="Diepolder">Helmut M. Diepolder</name>
<name sortKey="Gruner, Norbert H" sort="Gruner, Norbert H" uniqKey="Gruner N" first="Norbert H" last="Grüner">Norbert H. Grüner</name>
<name sortKey="Haas, Jurgen" sort="Haas, Jurgen" uniqKey="Haas J" first="Jürgen" last="Haas">Jürgen Haas</name>
<name sortKey="Heeg, Malte" sort="Heeg, Malte" uniqKey="Heeg M" first="Malte" last="Heeg">Malte Heeg</name>
<name sortKey="Horster, Sophia" sort="Horster, Sophia" uniqKey="Horster S" first="Sophia" last="Horster">Sophia Horster</name>
<name sortKey="Jung, Maria Christina" sort="Jung, Maria Christina" uniqKey="Jung M" first="Maria-Christina" last="Jung">Maria-Christina Jung</name>
<name sortKey="Kurktschiev, Peter" sort="Kurktschiev, Peter" uniqKey="Kurktschiev P" first="Peter" last="Kurktschiev">Peter Kurktschiev</name>
<name sortKey="Neumann Haefelin, Christoph" sort="Neumann Haefelin, Christoph" uniqKey="Neumann Haefelin C" first="Christoph" last="Neumann-Haefelin">Christoph Neumann-Haefelin</name>
<name sortKey="Schraut, Winfried" sort="Schraut, Winfried" uniqKey="Schraut W" first="Winfried" last="Schraut">Winfried Schraut</name>
<name sortKey="Spannagl, Michael" sort="Spannagl, Michael" uniqKey="Spannagl M" first="Michael" last="Spannagl">Michael Spannagl</name>
<name sortKey="Thimme, Robert" sort="Thimme, Robert" uniqKey="Thimme R" first="Robert" last="Thimme">Robert Thimme</name>
<name sortKey="Ulsenheimer, Axel" sort="Ulsenheimer, Axel" uniqKey="Ulsenheimer A" first="Axel" last="Ulsenheimer">Axel Ulsenheimer</name>
<name sortKey="W Chtler, Martin" sort="W Chtler, Martin" uniqKey="W Chtler M" first="Martin" last="W Chtler">Martin W Chtler</name>
<name sortKey="Zachoval, Reinhart" sort="Zachoval, Reinhart" uniqKey="Zachoval R" first="Reinhart" last="Zachoval">Reinhart Zachoval</name>
</noCountry>
<country name="Allemagne">
<region name="Bavière">
<name sortKey="Raziorrouh, Bijan" sort="Raziorrouh, Bijan" uniqKey="Raziorrouh B" first="Bijan" last="Raziorrouh">Bijan Raziorrouh</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeAllemagneV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000289 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000289 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    GrippeAllemagneV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:21763239
   |texte=   Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:21763239" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeAllemagneV3 

Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Tue Jul 7 11:47:10 2020. Site generation: Sat Sep 26 09:55:33 2020